Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Inebilizumab: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| B cell subset counts | downregulates | phenotype | 0.95 |
| Neuromyelitis Optica Spectrum Disorder | treats | disease | 0.90 |
| CD19+ B Cells | targets | cell_type | 0.90 |
| Cd19 | targets | biomarker | 0.90 |
| CD20 | targets | protein | 0.90 |
| B Cell | downregulates | cell_type | 0.90 |
| Neuromyelitis Optica | treats | disease | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CD20+ B Cells | targets | cell_type | 0.90 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||